130
Participants
Start Date
March 29, 2019
Primary Completion Date
January 2, 2020
Study Completion Date
January 2, 2020
SAR442168
Pharmaceutical form: Film coated tablet; Route of administration: Oral
Placebo
Pharmaceutical form: Film coated tablet; Route of administration: Oral
Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)
Pharmaceutical form: Solution for injection; Route of administration: Intravenous
Investigational Site Number 8040007, Zhytomyr
Investigational Site Number 2330001, Tallinn
Investigational Site Number 2030001, Prague
Investigational Site Number 2030002, Praha 5 - Motol
Investigational Site Number 7240005, Salt
Investigational Site Number 8040003, Vinnytsia
Investigational Site Number 7240001, Madrid
Investigational Site Number 7240004, Murcia
Investigational Site Number 2500003, Toulouse
Investigational Site Number 8400007, Savannah
Investigational Site Number 8400002, Maitland
Investigational Site Number 8400004, Sunrise
Investigational Site Number 8400009, Tampa
Investigational Site Number 8400005, Cullman
Investigational Site Number 8400003, Knoxville
Investigational Site Number 7240003, Seville
Investigational Site Number 8400006, Westerville
Investigational Site Number 2500001, Nantes
Investigational Site Number 8400008, Dayton
Investigational Site Number 7240006, Barakaldo
Investigational Site Number 8040005, Dnipro
Investigational Site Number 2030004, Hradec Králové
Investigational Site Number 2030006, Pardubice
Investigational Site Number 2500004, Nancy
Investigational Site Number 8040002, Chernivtsi
Investigational Site Number 2030003, Jihlava
Investigational Site Number 8400001, Northbrook
Investigational Site Number 2030007, Brno
Investigational Site Number 8040009, Odesa
Investigational Site Number 2500002, Strasbourg
Investigational Site Number 2030005, Ostrava - Poruba
Investigational Site Number 8040001, Lviv
Investigational Site Number 8040006, Lviv
Investigational Site Number 7030001, Bratislava
Investigational Site Number 6430003, Moscow
Investigational Site Number 6430002, Moscow
Investigational Site Number 6430005, Saint Petersburg
Investigational Site Number 6430004, Saint Petersburg
Investigational Site Number 6430001, Saint Petersburg
Investigational Site Number 6430006, Kazan'
Investigational Site Number 6430007, Tyumen
Investigational Site Number 1240002, Gatineau
Investigational Site Number 1240001, Greenfield Park
Investigational Site Number 1240003, Vancouver
Investigational Site Number 5280001, Amsterdam
Investigational Site Number 5280002, Sittard-Geleen
Investigational Site Number 7030002, Martin
Investigational Site Number 7240002, Barcelona
Lead Sponsor
Sanofi
INDUSTRY